There are 44 million Americans with thinning bones. Although osteoporosis is usually considered a “women’s condition,��? 20 percent of those diagnosed with dangerously weakened bones are men.
What causes this degeneration of bone? How can it be prevented, and what are the best treatments? Find out if the association of jawbone death with certain osteoporosis drug is significant or so rare it is not a real concern.
Guest: Felicia Cosman, MD, is Professor of Clinical Medicine at Columbia College of Physicians and Surgeons. She is an endocrinologist specializing in osteoporosis at the Helen Hayes Hospital in West Haverstraw, New York, and Clinical Director of the National Osteoporosis Foundation in Washington, DC.
Thomas Weber, MD, is Assistant Professor of Medicine at Duke University School of Medicine and Duke University Medical Center, where he is Medical Director of the Duke Clinical Bone Laboratory and Program Director for the fellowship training program in Endocrinology, Diabetes and Metabolism.